eXoZymes, Inc. (EXOZ)
Healthcare
Biotechnology
4.60 $
-1.1%
vs. previous close
Closing price · As of: 3. Aug 2026
eXoZymes, Inc. (EXOZ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -6.5 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -1.6 | -1.3 | -1.2 | -8.5 | -6.5 | |
| 0.1 | 0.1 | 0.2 | 0.3 | -0.1 | |
| 0.2 | 0.2 | 0.3 | 1.1 | 2.0 | |
| -0.5 | -0.2 | 0.2 | -4.0 | 0.4 | |
| 0.4 | 0.2 | 0.3 | 0.4 | 0.2 | |
| -0.3 | -0.1 | -0.3 | -0.4 | -0.2 | |
| – | – | – | 0.0 | 0.0 | |
| 2.3 | 1.4 | 1.0 | 19 | 0.0 | |
| 0.4 | 0.0 | -0.5 | 9.7 | -6.7 | |
| -2.0 | -1.4 | -1.5 | -8.9 | -6.7 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.